COVID-19 mRNA vaccine: safety and situation of clinical application

Gengchen Niu

doi:10.1117/12.2660328

6 December 2022 COVID-19 mRNA vaccine: safety and situation of clinical application

Gengchen Niu

Proceedings Volume 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022); 124581L (2022) https://doi.org/10.1117/12.2660328
Event: International Conference on Biomedical and Intelligent Systems, 2022, Chengdu, China

Abstract

The resulting Covid-19 pandemic has afflicted tens of millions of people to fight COVID-19 with the mRNA vaccine, which has provided good feedback but has also brought some adverse effects and complications. This paper demonstrates the great potential of MRA vaccines in fighting new tubes by introducing the mechanism and advantages of MNA vaccines and summarizes the adverse reactions found around the world after injection of mRNA vaccines and focuses on the three types of adverse reactions to discuss and tries to analyze their causes. Our work can draw public attention to adverse reactions to the MNA vaccine and accelerate the development of related technologies.

Citation Download Citation

Gengchen Niu "COVID-19 mRNA vaccine: safety and situation of clinical application", Proc. SPIE 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022), 124581L (6 December 2022); https://doi.org/10.1117/12.2660328

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available